Browsing Tag

Genocea Biosciences

Genocea Initiates Restructuring and Announces Plan to Explore Strategic Alternatives

Eli Pacheco Apr 29, 2022 0

CAMBRIDGE, Mass., April 28, 2022 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (Nasdaq: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today…

Health

Genocea to Present Clinical and Preclinical Data at AACR Annual Meeting

Eli Pacheco Mar 9, 2022 0

Company to present late-breaking clinical trial update for TiTAN trial of GEN-011, Genocea’s neoantigen-targeted peripheral T cell therapy for solid tumors The PLANET manufacturing…

Health

John Lunger, of Adaptimmune, Joins Genocea Biosciences’ Board of Directors

Eli Pacheco Mar 8, 2022 0

CAMBRIDGE, Mass., March 07, 2022 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (Nasdaq: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today…

Health

Genocea to Present at the 11th Annual SVB Leerink Global Healthcare Conference

Eli Pacheco Feb 11, 2022 0

CAMBRIDGE, Mass., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today…

Health

Genocea to Present at the Stifel 2021 Virtual Healthcare Conference

Eli Pacheco Nov 11, 2021 0

CAMBRIDGE, Mass., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (Nasdaq: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today…

Health

Genocea to Present at Upcoming Conferences

Eli Pacheco Sep 29, 2021 0

CAMBRIDGE, Mass., Sept. 28, 2021 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (Nasdaq: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, announced…